Figure 2: Analysis of capecitabine and its metabolites pharmacokinetics.

(A) Dose-AUC relationship of capecitabine, 5′-DFCR, 5′-DFUR and 5-FU; (B) Variability of capecitabine clearance between first and second pharmacokinetic measurements.

(A) Dose-AUC relationship of capecitabine, 5′-DFCR, 5′-DFUR and 5-FU; (B) Variability of capecitabine clearance between first and second pharmacokinetic measurements.